Skip to main content
Clinical Trials/CTRI/2024/03/064433
CTRI/2024/03/064433
Not yet recruiting
Phase 2

A RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF AYASKRITI IN DYSLIPIDEMIA - NI

DR GIRISH SM0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E782- Mixed hyperlipidemia
Sponsor
DR GIRISH SM
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR GIRISH SM

Eligibility Criteria

Inclusion Criteria

  • Subjects between age group of 20– 60 years, irrespective of gender.
  • Subjects fulfilling the diagnostic criteria.
  • Both freshly diagnosed and treated cases of Dyslipidemia
  • Fresh case means\-Newly diagnosed and untreated case of Dyslipidemia.
  • Treated case means \-Already diagnosed and treated case of Dyslipidemia.

Exclusion Criteria

  • Patients having any of the diagnosed systemic illnesses which intervene with the study
  • Patients having Uncontrolled Diabetes and Hypertension
  • Uncontrolled diabetes is defined as diabetics having RBS more than 250 mg per dl
  • Uncontrolled hypertension is defined as having blood pressure systolic more than 150 and diastolic more than 100 mm of Hg in spite of intake of antihypertensive medications
  • Pregnant Women and Lactating Mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials